Results 121 to 130 of about 43,579 (203)

Association of post-diagnostic use of cholera vaccine with survival outcome in breast cancer patients. [PDF]

Br J Cancer, 2021
Zheng G, Sundquist J, Sundquist K, Ji J.
europepmc   +1 more source

Do Oral Cholera Vaccine and Water, Sanitation, and Hygiene Combine to Provide Greater Protection Against Cholera? Results From a Cluster-Randomized Trial of Oral Cholera Vaccine in Kolkata, India. [PDF]

Open Forum Infect Dis
Im J, Islam MT, Ahmmed F, Kim DR, Tadesse BT, Kang S, Khanam F, Chowdhury F, Ahmed T, Firoj MG, Aziz AB, Hoque M, Jeon HJ, Kanungo S, Dutta S, Zaman K, Khan AI, Marks F, Kim JH, Qadri F, Clemens JD.   +20 more
europepmc   +1 more source

Effectiveness of one dose of killed oral cholera vaccine in an endemic community in the Democratic Republic of the Congo: A matched case-control study

, 2023
Malembaka EB, Bugeme PM, Hutchins C, Xu H, Hulse JD, Demby MN, Gallandat K, Saidi JM, Rumedeka BB, Itongwa M, Tshiwedi-Tsilabia E, Kitoga F, Bodisa-Matamu T, Kavunga-Membo H, Bengehya J, Kulondwa J, Debes AK, Taty N, Lee EC, Lunguya O, Lessler J, Leung DT, Cumming O, Okitayemba PW, Mukadi-Bamuleka D, Knee J, Azman AS.   +26 more
europepmc   +1 more source

Insights from Natural Infection-Derived Immunity to Cholera Instruct Vaccine Efforts [PDF]

, 2012
Marcela F. Pasetti, Myron M. Levine
openalex   +1 more source

Costing oral cholera vaccine delivery using a generic oral cholera vaccine delivery planning and costing tool (CholTool). [PDF]

Hum Vaccin Immunother, 2020
Morgan W, Levin A, Hutubessy RC, Mogasale V.   +3 more
europepmc   +1 more source

Long-Term Immunogenicity of Live Oral Cholera Vaccine CVD 103-HgR in Adolescents Aged 12-17 Years in the United States. [PDF]

Am J Trop Med Hyg, 2021
McCarty JM, Cassie D, Bedell L, Lock MD, Bennett S.   +4 more
europepmc   +1 more source

Anti-bacterial and anti-toxic immunity induced by a killed whole-cell-cholera toxin B subunit cholera vaccine is essential for protection against lethal bacterial infection in mouse pulmonary cholera model [PDF]

, 2012
S-S Kang, Jing Yang, Kiyoung Kim, Cheol‐Heui Yun, Jan Holmgren, Cécil Czerkinsky, Sung‐Hee Han   +6 more
openalex   +1 more source

Seroconversion and Kinetics of Vibriocidal Antibodies during the First 90 Days of Re-Vaccination with Oral Cholera Vaccine in an Endemic Population. [PDF]

Vaccines (Basel)
Chisenga CC, Phiri B, Ng'ombe H, Muchimba M, Musukuma-Chifulo K, Silwamba S, Laban NM, Luchen C, Liswaniso F, Chibesa K, Mubanga C, Mwape K, Simuyandi M, Cunningham AF, Sack D, Bosomprah S.   +15 more
europepmc   +1 more source

Parenteral Vaccination with a Cholera Conjugate Vaccine Boosts Vibriocidal and Anti-OSP Responses in Mice Previously Immunized with an Oral Cholera Vaccine. [PDF]

Am J Trop Med Hyg, 2021
Akter A, Kelly M, Charles RC, Harris JB, Calderwood SB, Bhuiyan TR, Biswas R, Xu P, Kováč P, Qadri F, Ryan ET.   +10 more
europepmc   +1 more source

Support for a cholera vaccine stockpile [PDF]

, 2012
Agnès Binagwaho, Thierry Nyatanyi, Cameron T. Nutt, Claire Wagner   +3 more
openalex   +1 more source